Feed aggregator

On 10 May, the cruise ship MV Hondius arrived at the port of Granadilla, Tenerife, Canary Islands. Passengers and crew continue to disembark and to be medically evacuated to their countries of origin. At disembarkation, they are all considered high-risk and repatriated, whether symptomatic or not, through non-commercial flights. 

The guidance published today by ECDC provides advice for public health professionals in the EU/EEA managing individuals potentially exposed to Andes hantavirus from the M/V Hondius, and for healthcare professionals and transport personnel involved in the disembarkation, transfer, and care of passengers and crew.

To the people of Tenerife,

My name is Tedros, and I serve as the Director-General of the World Health Organization, the United Nations agency responsible for global public health. It is not common for me to write directly to the people of a single community, but today I feel it is not only appropriate, it is necessary.

I want to speak to you directly, not through press releases or technical briefings, but as one human being to another, because you deserve that.

I know you are worried. I know that when you hear the word “outbreak” and watch a ship sail toward your shores, memories surface that none of us have fully put to rest. The pain of 2020 is still real, and I do not dismiss it for a single moment.

But I need you to hear me clearly: this is not another COVID. The current public health risk from hantavirus remains low. My colleagues and I have said this unequivocally, and I will say it again to you now.

The virus aboard the MV Hondius is the Andes strain of hantavirus. It is serious. Three people have lost their lives, and our hearts go out to their families. The risk to you, living your daily life in Tenerife, is low. This is the WHO’s assessment, and we do not make it lightly.

Right now, there are no symptomatic passengers on board. A WHO expert is on that ship. Medical supplies are in place. Spain’s authorities have prepared a careful, step-by-step plan: passengers will be ferried ashore at the industrial port of Granadilla, far from residential areas, in sealed, guarded vehicles, through a completely cordoned-off corridor, and repatriated directly to their home countries. You will not encounter them. Your families will not encounter them.

I also want to say something else, something that goes beyond the science.

I personally thanked Prime Minister Sanchez for Spain’s decision to receive this ship. I called it an act of solidarity and moral duty. Because that is what it is. I want you to know that the WHO’s request to Spain was not made arbitrarily. It was made in full accordance with the International Health Regulations, the legally binding framework that defines the rights and obligations of countries and the WHO when responding to public health events of international concern. Under those rules, the nearest port with sufficient medical capacity must be identified to ensure the safety and dignity of those on board. Tenerife met that standard. Spain honoured it. Nearly 150 people from 23 countries have been at sea for weeks, some of them grieving, all of them frightened, all of them longing for home. Tenerife has been chosen because it has the medical capacity, the infrastructure, and the humanity to help them reach safety.

And because I believe that so deeply, I will be there myself. I intend to travel to Tenerife to observe this operation firsthand, to stand alongside the health workers, port staff, and officials who are making it happen, and to personally pay my respects to an island that has responded to a difficult situation with grace, solidarity, and compassion. Your humanity deserves to be witnessed, not just acknowledged from a distance.

As I have said many times: viruses do not care about politics, and they do not respect borders. The best immunity any of us has is solidarity.

Tenerife is demonstrating that solidarity today. The ship’s captain, Jan Dobrogowski, crew and the company operating the vessel have shown exemplary collaboration at this challenging time.  On behalf of the World Health Organization, and on behalf of those passengers and their families around the world, I thank the people of Tenerife and everyone else involved.

Please take care of yourselves and of each other. Trust in the preparations that have been made. And know that the WHO stands with you, and with every person on that ship, every step of the way.

With respect, care, and gratitude,

Tedros

Dr Tedros Adhanom Ghebreyesus

Director-General, World Health Organization

Dr Tedros Adhanom Ghebreyesus, WHO Director-General, briefed media today on a cluster of hantavirus cases linked to a cruise ship, the MV Hondius.

Eight cases have been reported so far, including three deaths. Five of the 8 cases have been confirmed as hantavirus.

The hantavirus involved is the Andes virus, the only species known to be capable of limited transmission between humans, linked to close and prolonged contact.

Describing the situation, Dr Tedros said, “While this is a serious incident, WHO assesses the public health risk as low.” He noted that given the incubation period, “it’s possible that more cases may be reported.”

WHO is coordinating closely with multiple countries under the International Health Regulations or IHR, rules that define the rights and obligations of countries and WHO in responding to public health events. This event demonstrates why the IHR exist, demonstrating the importance of global cooperation and solidarity in responding to health threats that know no borders.

“Our priorities are to ensure the affected patients receive care, that the remaining passengers on the ship are kept safe and treated with dignity, and to prevent any further spread of the virus,” Dr Tedros said.

WHO has taken a number of actions since it was notified of the situation on Saturday, 2 May 2026. The latest of these include deploying an expert on board the ship, to support a comprehensive medical assessment of all passengers and crew, while gathering critical information to evaluate their risk of infection.

WHO has arranged for the shipment of 2500 diagnostic kits from Argentina to laboratories in five countries to strengthen testing capacity. The Organization is also developing step-by-step operational guidance for the safe and respectful disembarkation and onward travel of passengers and crew when they arrive.

Watch the full press conference

 

Despite advancements in detection and treatment, a new report reveals severe shortfalls in reaching the indicators for the Sustainable Development Goal target for HIV, tuberculosis, viral hepatitis and sexually transmitted infections (STIs) by 2030. More action remains necessary to prevent thousands of annual deaths and slow the rising number of STI diagnoses across Europe.

ECDC has deployed an expert from the EU Health Task Force to the cruise ship affected by the Andes hantavirus outbreak, as part of a joint effort to investigate the outbreak and coordinate the public health response together with relevant Member States.

ECDC is launching episomer, a customisable tool designed to support epidemic intelligence activities through the monitoring of social media data.

Hantavirus infection has been laboratory-confirmed in two individuals in connection with the cluster of illness reported on a cruise ship.

Hantavirus infection has been laboratory-confirmed in two individuals in connection with the cluster of illness reported on a cruise ship.

ECDC, through the EU Health Task Force, supported a two-day after-action review in Slovakia to analyse response efforts to a large multi-country outbreak of hepatitis A virus and to strengthen preparedness for future events.

Marking WHHD, ECDC is publishing proposed guidance for IPC programmes in healthcare facilities and introducing hyFive, a digital tool to support hand hygiene monitoring and data-driven implementation.

A cluster of severe acute respiratory illness, including three deaths and one severely ill individual, has been reported among passengers on a cruise ship travelling in the Atlantic and registered in the Netherlands. The ship is currently located off the coast of Cabo Verde, with 149 people on board.

ECDC is aware of suspected cases of hantavirus infection, including three deaths, associated with a cruise ship travelling in the Atlantic.

Ten years ago, the UN Security Council unanimously adopted Resolution 2286 on health care in armed conflicts. The situation is even worse compared to 10 years ago. Today, we mark not an achievement – we mark a failure. As violence affecting medical facilities, transport and personnel continues unabated, the harm this resolution sought to prevent has not diminished. It has continued and, in many contexts, intensified. As the heads of the International Committee of the Red Cross (ICRC), the World Health Organization (WHO), and Médecins Sans Frontières (MSF), we join others in the international community in issuing an urgent call for action.

Member States of the World Health Organization (WHO) have progressed work on the Pathogen Access and Benefit Sharing (PABS) annex, a key part of the WHO Pandemic Agreement, and today agreed additional time was needed to finalize the framework for ensuring a better, more equitable, response to future pandemics.

Countries today ended the resumed session of the sixth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement in Geneva, focused on the PABS system. The outcome of this work will be presented to the Seventy-ninth World Health Assembly (WHA) later this month. Given the need for further negotiations, the Assembly will be asked to consider continuing IGWG’s work as mandated in Resolution WHA78.1 and submit the outcome to the next Assembly in May 2027, or earlier by a special session of WHA in 2026.

“Real progress was made on the PABS annex and I am confident through continued negotiations differences will be overcome,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “Member States should continue approaching the outstanding issues with a sense of urgency because the next pandemic is a matter of when, not if. The PABS annex is the last piece of the puzzle not only for the Pandemic Agreement but all initiatives that WHO and Member States have implemented as a result of lessons learned from the COVID-19 pandemic.”

The PABS system is intended to ensure, on equal footing, the rapid sharing of pathogens with pandemic potential and the fair and equitable sharing of benefits arising from their use, such as vaccines, diagnostics and therapeutics. Finalizing the PABS Annex is necessary so countries can proceed with signature and ratification of the Pandemic Agreement.

“Finalizing a document of such technical and legal complexity requires precision and dedication, both of which the Member States have demonstrated in full,” said IGWG Bureau Co-Chair Ambassador Tovar da Silva Nunes of Brazil. “We are not there yet, but with an extension of our negotiations, we will get there.”

IGWG Co-Chair Mr Matthew Harpur said: “WHO Member States have demonstrated strong and continuing commitment to negotiations on a Pathogen Access and Benefit Sharing system annex. The IGWG Bureau is confident we are moving in the right direction to finalize the PABS annex, and in doing so provide the WHO Pandemic Agreement with the framework needed to ensure countries are better, and more equitably, prepared and protected for the next pandemic.”

The IGWG will hold its seventh meeting from 6 to 17 July 2026.

In May 2025, the World Health Assembly adopted the WHO Pandemic Agreement to strengthen how countries prevent, prepare for, and respond to pandemics. It also established an open-ended Intergovernmental Working Group (IGWG) to carry out key tasks, including drafting and negotiating the PABS system.  

 

The new monthly surveillance report from the European Centre of Disease Prevention and Control (ECDC) provides updated data on mpox in Europe and shows that clade I transmission is still ongoing in several EU/EEA countries.

ECDC presented its new open-source event-based surveillance platform, Epi+, at Luxembourg’s PHRESH General Assembly, highlighting how the tool will strengthen national coordination, data sharing and early detection of health threats.

The World Health Organization (WHO) has validated Australia for eliminating trachoma as a public health problem, marking a significant milestone in the health of indigenous peoples and in global efforts to combat neglected tropical diseases (NTDs). Trachoma, the world’s leading infectious cause of blindness, no longer represents a public health problem in the country.

On 27-28 April 2026, ECDC hosted the second meeting of the European Union Reference Laboratories for Public Health (EURL-PH) network in Stockholm.

Global efforts to combat viral hepatitis are delivering measurable progress in reducing infections and deaths, but the disease remains a major global health challenge, according to a new World Health Organization (WHO) report released today at the World Hepatitis Summit.

Viral hepatitis B and C – the two infections responsible for 95% of hepatitis-related deaths worldwide – claimed 1.34 million lives in 2024, the latest data show. At the same time, transmission continues, with more than 4900 new infections every day, or 1.8 million each year.

The 2026 Global hepatitis report documents significant gains made since 2015. The annual number of new hepatitis B infections has dropped by 32% and hepatitis C-related deaths have fallen by 12% globally. Hepatitis B prevalence among children under five has also decreased to 0.6%, with 85 countries achieving or surpassing the 2030 target of 0.1%.

These achievements reflect the impact of sustained, coordinated global and national action following the adoption of WHO viral hepatitis elimination targets by Member States at the World Health Assembly in 2016. However, the report warns that current rates of progress are insufficient to meet all 2030 elimination targets, underscoring the urgent need to accelerate prevention, testing, and treatment efforts worldwide.

“Around the world, countries are showing that eliminating hepatitis is not a pipedream, it's possible with sustained political commitment, backed by reliable domestic financing,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “At the same time, this report shows that progress is too slow and uneven. Many people remain undiagnosed and untreated due to stigma, weak health systems and inequitable access to care. While we have the tools to eliminate hepatitis as a public health threat, urgent scale-up of prevention, diagnosis and treatment is needed if the world is to meet the 2030 targets.”

Global burden and gaps in response

Updated WHO estimates indicate that 287 million people were living with chronic hepatitis B or C infection in 2024.

That year, 0.9 million people were newly infected with hepatitis B. The WHO African Region accounted for 68% of new hepatitis B infections, yet only 17% of newborns in the region received the hepatitis B birth-dose vaccination.

A further 0.9 million hepatitis C infections were recorded in 2024. People who inject drugs accounted for 44% of new infections, highlighting the urgent need for stronger harm reduction services and safe injection practices.

Of the 240 million people with chronic hepatitis B in 2024, fewer than 5% were receiving treatment. Only 20% of people with hepatitis C have been treated since 2015, when a new 12-week treatment with a cure rate of about 95% became available.

As a result of limited access to prevention and care, in 2024 an estimated 1.1 million people died from hepatitis B and 240 000 from hepatitis C. Liver cirrhosis and hepatocellular carcinoma were the main causes of hepatitis related deaths. A large share of hepatitis B-related deaths occurred in the African and Western Pacific Regions.

Ten countries – Bangladesh, China, Ethiopia, Ghana, India, Indonesia, Nigeria, the Philippines, South Africa and Viet Nam – accounted for 69% of hepatitis B related deaths worldwide in 2024. Hepatitis C-related deaths are more geographically dispersed. In 2024, ten countries accounted for 58% of the global total: China, India, Indonesia, Japan, Nigeria, Pakistan, the Russian Federation, South Africa, the United States of America and Viet Nam.

Proven solutions

Despite these challenges, progress in countries such as Egypt, Georgia, Rwanda, and the United Kingdom demonstrates that eliminating hepatitis as a public health problem is achievable with sustained commitment and investment.

Highly effective tools are already available:

• hepatitis B vaccine protects more than 95% of vaccinated people against both acute and chronic infections;
• long-term antiviral treatment for hepatitis B can help effectively manage chronic infection and prevent severe liver disease; and
• hepatitis C short-course curative therapy lasting 8-12 weeks can cure more than 95% of infections.

“The data shows that progress is possible but also reveals where we are falling short. Every missed diagnosis and untreated infection due to chronic viral hepatitis represents a preventable death,” said Dr Tereza Kasaeva, Director, WHO Department for HIV, TB, Hepatitis and Sexually Transmitted Infections. “Countries must move faster to integrate hepatitis services for people living with hepatitis B and C into primary care, and to reach the communities most affected.”

The report identifies priority actions to accelerate hepatis elimination as a public health threat. These include scaling up treatment for chronic hepatitis B infection, particularly in the WHO African and Western Pacific regions, and expanding access to hepatitis C treatment in the WHO Eastern Mediterranean Region.

It also calls for stronger political commitment and financing, improved coverage of hepatitis B birth-dose vaccination and expanded antiviral prophylaxis to prevent mother-to-child transmission of HBV infection, particularly in the WHO African Region. In addition, the report emphasizes the need to improve injection safety in both health-care settings and community practices, including through strengthened harm reduction services for people who inject drugs.